Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ALT | LRMR | BVS | ||
Company | Altimmune Inc | Larimar Therapeutics Inc | Bioventus Inc Cl A | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 6.77 | 7.74 | 5.82 | ||
High | 7.00 | 7.83 | 6.20 | ||
Low | 6.52 | 7.51 | 5.67 | ||
Last | 6.60 | 7.63 | 5.89 | ||
Change | -0.14 | -0.08 | +0.11 | ||
% Change | -2.08% | -1.04% | +1.90% | ||
Volume | 1,908,200 | 164,900 | 558,100 | ||
20-Day Average Volume | 5,072,640 | 650,790 | 708,860 | ||
Previous Close | 6.74 | 7.71 | 5.78 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 6.54 | 8.39 | 6.06 | ||
20-Day Raw Stochastic | 33.68% | 24.41% | 34.66% | ||
20-Day Relative Strength | 46.93% | 47.48% | 50.43% | ||
Weighted Alpha | +6.16 | +31.46 | +60.57 | ||
Today's Opinion | 48% Sell | 8% Buy | 72% Buy | ||
Previous Opinion | 48% Sell | 24% Buy | 72% Buy | ||
Last Month's Opinion | 32% Sell | 72% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +5.52% since 06/26/24 | +8.69% since 06/26/24 | +5.18% since 06/26/24 | ||
Low | 6.06 on 06/27/24 | 6.92 on 06/27/24 | 5.47 on 07/01/24 | ||
High | 7.47 on 07/02/24 | 8.40 on 07/01/24 | 6.20 on 07/03/24 | ||
1-Month | |||||
%Chg | -11.88% since 06/03/24 | -16.52% since 06/03/24 | -12.09% since 06/03/24 | ||
Low | 5.64 on 06/18/24 | 6.80 on 06/26/24 | 5.28 on 06/26/24 | ||
High | 8.49 on 06/24/24 | 10.20 on 06/13/24 | 7.04 on 06/12/24 | ||
3-Month | |||||
%Chg | -28.96% since 04/03/24 | -1.17% since 04/03/24 | +17.33% since 04/03/24 | ||
Low | 5.64 on 06/18/24 | 5.91 on 04/25/24 | 3.90 on 04/30/24 | ||
High | 9.52 on 04/04/24 | 10.20 on 06/13/24 | 7.04 on 06/12/24 | ||
6-Month | |||||
%Chg | -33.53% since 01/03/24 | +56.35% since 01/03/24 | +12.84% since 01/03/24 | ||
Low | 5.64 on 06/18/24 | 4.09 on 01/17/24 | 3.90 on 04/30/24 | ||
High | 14.84 on 02/28/24 | 13.68 on 02/15/24 | 7.04 on 06/12/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 467,953 | 486,809 | 466,288 | ||
Shares Outstanding, K | 70,902 | 63,802 | 79,166 | ||
Annual Sales | 430,000 | 0 | 512,350,000 | ||
Annual Net Income | -88,450,000 | -36,950,000 | -156,230,000 | ||
Last Quarter Sales | 10,000 | 0 | 129,460,000 | ||
Last Quarter Net Income | -24,390,000 | -14,650,000 | -4,570,000 | ||
60-Month Beta | 0.13 | 1.01 | 0.84 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.34 on 05/09/24 | -0.27 on 05/09/24 | 0.07 on 05/07/24 | ||
Latest Earnings Date | 08/08/24 | 08/08/24 | 08/13/24 | ||
Most Recent Dividend | 2.910 on 02/06/17 | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 17.52 |